Mainz BioMed N.V. | Finanzwire

Basculer en Français

8302	Companies
115121	Keywords
55446	Articles
62530	Press releases

Home
Companies
Mainz BioMed N.V.

BRIEF

published on 03/18/2024 at 13:06, 8 months 3 days ago

Mainz Biomed Hosts Webinar on Colorectal Cancer Early Detection

Webinar Early Detection Mainz Biomed Colorectal Cancer Diagnostic Options
PRESS RELEASE

published on 03/18/2024 at 13:01, 8 months 3 days ago

Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options
Mainz Biomed to host webinar on Early Detection of Colorectal Cancer - Explore new laboratory diagnostic options on March 20, 2024. Event targets pharmacists, physicians, and healthcare professionals

Webinar Early Detection Mainz Biomed Colorectal Cancer Laboratory Diagnostic
BRIEF

published on 03/12/2024 at 14:06, 8 months 9 days ago

Mainz Biomed Showcases ColoAlert® at the 39th UDH Congress, Reinforcing its Commitment to Cancer Detection Innovation

Healthcare Innovation Cancer Screening Mainz Biomed ColoAlert® Molecular Diagnostics
PRESS RELEASE

published on 03/12/2024 at 14:01, 8 months 9 days ago

Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations
Mainz Biomed presents ColoAlert at UDH Congress 2024, showcasing evidence-based cancer screening innovations. Learn more at mainzbiomed.com

Cancer Screening ColoAlert Mainz Biomed UDH Congress 2024 Molecular Genetics
BRIEF

published on 03/05/2024 at 14:06, 8 months 16 days ago

Mainz Biomed Joins Forces with Trusted Health Advisors for U.S. Launch of Colorectal Cancer Diagnostic Tool

Partnership Mainz Biomed Colorectal Cancer Diagnostic Test THA
PRESS RELEASE

published on 03/05/2024 at 14:01, 8 months 16 days ago

Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic
Mainz Biomed partners with Trusted Health Advisors to support U.S. go-to-market strategy for next generation early colorectal cancer diagnostic

Partnership Diagnostic Mainz Biomed Colorectal Cancer Trusted Health Advisors
PRESS RELEASE

published on 02/27/2024 at 14:01, 8 months 23 days ago

Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical Community
Mainz Biomed to showcase ColoAlert® at Gynecology Conference in Stuttgart, Germany, highlighting the importance of early CRC detection and gynecologists' role in screenings

ColoAlert Mainz Biomed Gynecology Conference CRC Screening Early Cancer Detection
BRIEF

published on 02/27/2024 at 14:01, 8 months 23 days ago

Mainz Biomed presents its innovations at the gynecology congress in Stuttgart

ColoAlert Mainz Biomed Colorectal Cancer Screening Gynecology
BRIEF

published on 02/22/2024 at 14:01, 8 months 28 days ago

Mainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert®

ColoAlert Diagnostic Mainz Biomed Colorectal Cancer Praxisdienst
PRESS RELEASE

published on 02/22/2024 at 14:01, 8 months 28 days ago

Mainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert®
Mainz Biomed partners with Praxisdienst to distribute ColoAlert®, an innovative at-home stool test for colorectal cancer detection. The collaboration aims to improve healthcare by enhancing early diagnosis

ColoAlert Mainz Biomed Colorectal Cancer Praxisdienst Distribution Partnership

Accesswire

Published on 11/21/2024 at 22:05, 58 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 1 hour 13 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 2 hours 48 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 2 hours 53 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 20:00, 3 hours 3 minutes ago

Victory for New York Homeowners: Petroff Amshen LLP Blocks Lender’s Repeated Foreclosure Attempt

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 4 hours 2 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 4 hours 27 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 5 hours 5 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 5 hours 11 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 5 hours 12 minutes ago

2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.

Les Echos

Published on 11/21/2024 at 06:58, 16 hours 5 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 3 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 5 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 5 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 15 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE